Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Share-based Compensation (2021 - 2025)

Core Scientific's Share-based Compensation history spans 5 years, with the latest figure at $27.9 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 16.56% year-over-year to $27.9 million; the TTM value through Dec 2025 reached $98.2 million, up 89.19%, while the annual FY2025 figure was $98.2 million, 89.19% up from the prior year.
  • Share-based Compensation for Q4 2025 was $27.9 million at Core Scientific, down from $29.9 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $111.0 million in Q2 2022 and bottomed at -$1.1 million in Q1 2024.
  • The 5-year median for Share-based Compensation is $16.9 million (2022), against an average of $21.5 million.
  • The largest annual shift saw Share-based Compensation surged 5096.54% in 2022 before it plummeted 108.64% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $7.9 million in 2021, then skyrocketed by 106.26% to $16.3 million in 2022, then rose by 6.93% to $17.5 million in 2023, then soared by 37.13% to $24.0 million in 2024, then grew by 16.56% to $27.9 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Share-based Compensation are $27.9 million (Q4 2025), $29.9 million (Q3 2025), and $24.2 million (Q2 2025).